Current Perspectives in Adult Glioblastoma
VOORHEES, N.J., April 29 /PRNewswire/ -- Adult glioblastoma continues to be a difficult disease to treat, so healthcare professionals must have the most up-to-date information regarding optimal methods for diagnostic imaging and treatment of these tumors. Awareness of novel agents in clinical trials is also critical to providing the best care.
To address the need for current education on adult glioblastoma diagnosis and treatment, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a series of complimentary continuing education lectures at healthcare centers throughout the United States titled Current Perspectives in Adult Glioblastoma. This activity is supported by an educational grant from Merck.
Experts in neurology, neuro-oncology, and neurosurgery from leading medical institutions across the country will serve as faculty for this series, which is chaired by Marc C. Chamberlain, MD. Dr. Chamberlain is professor of neurology and neurological surgery and chief of the division of neuro-oncology at the University of Washington in Seattle.
Healthcare professionals can visit www.RMEI.com/GBlectures today to schedule a meeting at their institution.
RMEI is a medical education company that specializes in independent, continuing medical education designed for clinicians to improve and deliver quality medical care to patients. The goal of RMEI educational offerings is to promote continuous professional development and the improvement of health outcomes. RMEI works closely with medical experts to develop activities that improve diagnosis and treatment leading to better outcomes for patients. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.
For other educational opportunities, please visit www.RMEI.com.
SOURCE Robert Michael Educational Institute LLC